Daniel Salain - Sep 28, 2022 Form 3 Insider Report for IDERA PHARMACEUTICALS, INC. (IDRA)

Role
Chief Operating Officer
Signature
/s/ John J. Kirby, Attorney-in-Fact for Daniel Salain
Stock symbol
IDRA
Transactions as of
Sep 28, 2022
Transactions value $
$0
Form type
3
Date filed
9/30/2022, 09:44 PM
Next filing
Jan 19, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney